Interview
AlzeCure Pharma: “We have good momentum”
AlzeCure Pharma, which develops small molecule drugs for the treatment of Alzheimer's disease and pain, is currently in the process of a rights issue...
AlzeCure's CEO: "Increased interest after EIC grant and FDA feedback"
Today marks the start of the subscription period for AlzeCure Pharma's rights issue,...
Professor about the Lipum collaboration: “We want to be able to individualize treatment of RA”
Lipum collaborates with Karolinska Institutet and Linköping University...
Curasight CEO: “We will deliver important milestones in the next 12 months”
Curasight works with the goal of transforming cancer care through...
Spago stays on schedule – green light for phase I/IIa study
Following a positive safety review, Spago Nanomedical's phase...
Xintela's CEO comments on the latest progress
2025 has been full of activities so far for...
AdjuTec Pharma wants to give new power to antibiotics
Antimicrobial resistance poses a growing threat to the...
New chapter for PHI as Eschricht returns as CEO
Patrik Eschricht is back as CEO of Phase...
Prolight's CSO reflects on positive pre-clinical results and looks ahead to key milestones in Q2
Prolight Diagnostics has taken an important step forward...
Chordate Medical's CEO comments on the quarterly report
For Chordate Medical, the first quarter of 2025 has been marked by...
Strike Pharma takes the next step – new CEO and move to Lund
Per Norlén has taken over as CEO of Strike...
Promising preliminary results for Elicera Therapeutics CAR T-cell study
Preliminary results from the first patient cohort in Elicera...
Notes
Mentice consolidates operations to Denver
Bio-Works secures million-dollar order from global pharmaceutical company
OncoZenge receives investment proceeds from Yangtian Bio-Pharmaceutical
Xspray Pharma confirms bioequivalence for XS003
Evaxion converts debt of EUR 3,5 million
NEWSLETTER
NEWS
AI-designed proteins are created in seconds
The price of Leqembi needs to be lowered in Japan
Merck gears up in lung diseases with giant acquisition
Upcoming events!
Investing in Life Science
Discover unparalleled opportunities, set in the vibrant heart of Stockholm. This premier event unites forward-thinking investors and business leaders to...
Life Science Summit
The Nordic region's leading forum for early-stage and growth-phase life science companies. The Summit bridges innovation and capital by providing...
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account
Chronicles
The market is taking Trump's tariff threat in stride
The EU's new life science strategy – a step in the right direction or just fluff?
